Search results for "Placement."

showing 10 items of 1123 documents

Enzyme replacement therapy for mucopolysaccharidosis VI: evaluation of long-term pulmonary function in patients treated with recombinant human N-acet…

2010

Pulmonary function is impaired in untreated mucopolysaccharidosis type VI (MPS VI). Pulmonary function was studied in patients during long-term enzyme replacement therapy (ERT) with recombinant human arylsulfatase B (rhASB; rhN-acetylgalactosamine 4-sulfatase). Pulmonary function tests prior to and for up to 240 weeks of weekly infusions of rhASB at 1 mg/kg were completed in 56 patients during Phase 1/2, Phase 2, Phase 3 and Phase 3 Extension trials of rhASB and the Survey Study. Forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1) and, in a subset of patients, maximum voluntary ventilation (MVV), were analyzed as absolute volume in liters. FEV1 and FVC showed little change f…

Arylsulfatase BAdultmedicine.medical_specialtyVital capacityAdolescentMucopolysaccharidoses (MPS)N-Acetylgalactosamine-4-SulfataseMucopolysaccharidosis type VIClinical SciencesUrologyPulmonary function testingPlacebos03 medical and health sciencesFEV1/FVC ratio0302 clinical medicineRare DiseasesDouble-Blind MethodClinical ResearchmedicineGeneticsHumansGenetics(clinical)Longitudinal StudiesChildPreschoolLungGenetics (clinical)Genetics & Heredity0303 health sciencesLungMucopolysaccharidosis VIbusiness.industry030305 genetics & heredityEvaluation of treatments and therapeutic interventionsMucopolysaccharidosis VIEnzyme replacement therapyRecombinant Proteins3. Good healthSurgeryRespiratory Function Testsmedicine.anatomical_structureCross-Sectional StudiesResearch DesignChild Preschool6.1 PharmaceuticalsOriginal Articlebusiness030217 neurology & neurosurgery
researchProduct

Atherogenic lipoprotein phenotype and LDL size and subclasses in patients with growth hormone deficiency before and after short-term replacement ther…

2007

Atherogenic lipoprotein LDL size and subclasses growth hormone replacement therapy
researchProduct

SAL—A Novel Quality Measure for the Verification of Quantitative Precipitation Forecasts

2008

Abstract A novel object-based quality measure, which contains three distinct components that consider aspects of the structure (S), amplitude (A), and location (L) of the precipitation field in a prespecified domain (e.g., a river catchment) is introduced for the verification of quantitative precipitation forecasts (QPF). This quality measure is referred to as SAL. The amplitude component A measures the relative deviation of the domain-averaged QPF from observations. Positive values of A indicate an overestimation of total precipitation; negative values indicate an underestimation. For the components S and L, coherent precipitation objects are separately identified in the forecast and obser…

Atmospheric ScienceMatching (statistics)MeteorologyforecastDiagramprecipitationForecast verificationMeasure (mathematics)Displacement (vector)AmplitudeQuantitative precipitation forecastPrecipitationverificationWolkenphysik und VerkehrsmeteorologieradarMathematicsMonthly Weather Review
researchProduct

Intraoperative Evaluation of the Reconstruction of the Atrioventricular Valves by Means of Transesophageal Echocardiography

1989

In 44 operations, the mitral valve was reconstructed in 28 patients, the tricuspid valve in 12, and both atrioventricular (AV) valves in four. The results of reconstruction were tested first in the open arrested heart by injection of a crystalloid solution into the left or right ventricle, either through the reconstructed valve or via one of the great arteries. Upon termination of cardiopulmonary bypass the valve function was examined in the beating heart by transesophageal contrast echocardiography (TEE). For purposes of visualization, 0.5–1.0 cc of agitated Gelifundol was injected into the ventricle. In 31 patients, open testing and echocardiographic visualization showed identical, good o…

Atrioventricular valvemedicine.medical_specialtyMitral valve repairTricuspid valvebusiness.industrymedicine.medical_treatmentlaw.inventionmedicine.anatomical_structureValve replacementVentriclelawGreat arteriesInternal medicineMitral valvemedicineCardiopulmonary bypassCardiologybusiness
researchProduct

Safety, tolerability, pharmacokinetics, pharmacodynamics, and exploratory efficacy of the novel enzyme replacement therapy avalglucosidase alfa (neoG…

2019

This multicenter/multinational, open-label, ascending-dose study (NCT01898364) evaluated safety, tolerability, pharmacokinetics, pharmacodynamics, and exploratory efficacy of repeat-dose avalglucosidase alfa (neoGAA), a second-generation, recombinant acid α-glucosidase replacement therapy, in late-onset Pompe disease (LOPD). Patients ≥18 years, alglucosidase alfa naïve (Naïve) or previously receiving alglucosidase alfa for ≥9 months (Switch), with baseline FVC ≥50% predicted and independently ambulatory, received every-other-week avalglucosidase alfa 5, 10, or 20 mg/kg over 24 weeks. 9/10 Naïve and 12/14 Switch patients completed the study. Avalglucosidase alfa was well-tolerated; no deaths…

Avalglucosidase alfa (neoGAA)0301 basic medicineMaleGLUCOSE TETRASACCHARIDELysosomal acid alpha-glucosidase (GAA) deficiencyCHILDRENPulmonary function testingMOTOR FUNCTION0302 clinical medicineMedicineGenetics (clinical)Late-onset Pompe disease (LOPD)Glycogen Storage Disease Type IIAlglucosidase alfaMOUSE MODELEnzyme replacement therapyMiddle AgedTreatment OutcomeNeurologyTolerabilityEnzyme replacement therapySKELETAL-MUSCLEFemaleLife Sciences & BiomedicineMUSCLE TRAINING RMTGlycogen6-MINUTE WALKmedicine.drugAdultmedicine.medical_specialtyClinical NeurologyGLYCOGEN03 medical and health sciencesFEV1/FVC ratioPharmacokineticsInternal medicineHumansEnzyme Replacement TherapyAdverse effectAlglucosidase alfaScience & Technologybusiness.industryNeurosciencesalpha-GlucosidasesADULTSGlycogen storage disease type IISEVERITY030104 developmental biologyPharmacodynamicsPediatrics Perinatology and Child HealthNeurosciences & NeurologyNeurology (clinical)Glucan 14-alpha-Glucosidasebusiness030217 neurology & neurosurgeryNeuromuscular Disorders
researchProduct

On the instability of an axially moving elastic plate

2010

Problems of stability of an axially moving elastic band travelling at constant velocity between two supports and experiencing small transverse vibrations are considered in a 2D formulation. The model of a thin elastic plate subjected to bending and tension is used to describe the bending moment and the distribution of membrane forces. The stability of the plate is investigated with the help of an analytical approach. In the frame of a general dynamic analysis, it is shown that the onset of instability takes place in the form of divergence (buckling). Then the static forms of instability are investigated, and critical regimes are studied as functions of geometric and mechanical problem param…

AxiallyPlateBendingAnalytical solutionsInstabilityDisplacement (vector)symbols.namesakeMaterials Science(all)Modelling and SimulationGeneral Materials ScienceMathematicsApplied MathematicsMechanical EngineeringInstabilityMechanicsCondensed Matter PhysicsPoisson's ratioTransverse planeClassical mechanicsBucklingElasticMechanics of MaterialsModeling and SimulationBending momentsymbolsMovingliikkuminenThinAxial symmetryInternational Journal of Solids and Structures
researchProduct

Reduction in insulin sensitivity and inadequate β-cell capacity to counteract the increase in insulin resistance in children with idiopathic growth h…

2014

Purpose: To evaluate the performance of various indexes of insulin sensitivity and secretion and to identify the most useful indicator of deterioration of glucose metabolism in a cohort of children with growth hormone (GH) deficiency (GHD) during GH treatment. Methods: In 73 GHD children (55 M, 18 F; mean age 10.5 years) at baseline and after 12 months of treatment, we evaluated a number of surrogate indexes of insulin secretion and sensitivity. In a subgroup of 11 children we also performed an euglycemic hyperinsulinemic clamp. Results: After 12 months, a significant increase in fasting glucose (p < 0.001) and HbA1c levels (p < 0.001) was documented, despite all children remained with a no…

Blood GlucoseMalemedicine.medical_specialtyAdolescentHormone Replacement TherapyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentChildren; Glucose metabolism; Growth hormone treatment; Insulin secretion; Insulin sensitivity; Endocrinology Diabetes and Metabolism; EndocrinologyHypopituitarismCarbohydrate metabolismHypopituitarismSettore MED/13 - EndocrinologiaEndocrinologyInsulin resistanceInsulin-Secreting CellsInternal medicinemedicineHormone replacement therapy (male-to-female)HumansInsulinGrowth hormone treatmentChildDwarfism PituitaryChildrenGlucose metabolismGlucose tolerance testmedicine.diagnostic_testHuman Growth Hormonebusiness.industryInsulin secretionInsulinGlucose Tolerance TestInsulin sensitivitymedicine.diseaseGrowth hormone treatmentTreatment OutcomeEndocrinologyChild PreschoolConcomitantFemaleInsulin Resistancebusiness
researchProduct

The mechanisms of thrombotic risk induced by hormone replacement therapy.

2001

Abstract Objective : To review the available information on the action of hormones on the mechanisms involved in thrombotic risk. Results and Conclusions : Thrombosis plays a crucial role in the genesis and progression of both coronary heart disease (CHD) and venous thromboembolic disease (VTED), the two main forms of cardiovascular disease. Two main determinants of the thromboembolic phenotype, hypercoagulable state and altered endothelium, accumulate much of the work performed on the influence of hormones on thrombosis. Information has accumulated mainly for oestrogens, but increasing evidences support a role for progestogens. The sensitivity of each of the three components of the hemosta…

Blood PlateletsMalemedicine.medical_specialtyArteriosclerosismedicine.medical_treatmentCoronary DiseaseDiseaseBioinformaticsFibrinogenGeneral Biochemistry Genetics and Molecular Biologychemistry.chemical_compoundRisk FactorsInternal medicineFibrinolysismedicineHumansHormone replacement therapyEndothelial dysfunctionAgedVenous ThrombosisHemostasisFactor VIIbusiness.industryAntithrombinEstrogen Replacement TherapyObstetrics and GynecologyEstrogensMiddle Agedmedicine.diseasePostmenopauseEndocrinologyPhenotypechemistryHemostasisFemaleEndothelium Vascularbusinessmedicine.drugMaturitas
researchProduct

The effect of hormone replacement therapy on Ca2+ mobilization and P-selectin (CD62P) expression in platelets examined under flow cytometry.

2004

A series of events, such as increase of cytoplasmic free calcium (Ca 2+ ) and expression of P-selectin (CD62P), an adhesion molecule, on the platelet surface, are significant indicators of platelet activation. We have used flow cytometry to examine Ca 2+ mobilization and CD62P expression in platelets in whole blood obtained in women prior to, and after, different forms of hormone replacement therapy. Thirty-two women completed a protocol consisting of two consecutive 1-month periods under oestradlol (E 2 ), administered orally (2 mg/day) or transdermally (50 μg/day) in random order, followed by a 4-week transdermal sequential regime, in which, during the last 14 days, either progesterone (3…

Blood Plateletsmedicine.medical_specialtyCytoplasmP-selectinHormone Replacement Therapychemistry.chemical_compoundInternal medicinemedicineMedroxyprogesterone acetateHumansPlateletPlatelet activationWhole bloodTransdermalEstradiolHematologyGeneral MedicineMiddle AgedPlatelet ActivationAdenosine diphosphateP-SelectinEndocrinologychemistryGene Expression RegulationCalciumFemaleMenopauseHormonemedicine.drugBlood coagulationfibrinolysis : an international journal in haemostasis and thrombosis
researchProduct

Physically-Based Approach to the Mechanics of Strong Non-Local Linear Elasticity Theory

2009

In this paper the physically-based approach to non-local elasticity theory is introduced. It is formulated by reverting the continuum to an ensemble of interacting volume elements. Interactions between adjacent elements are classical contact forces while long-range interactions between non-adjacent elements are modelled as distance-decaying central body forces. The latter are proportional to the relative displacements rather than to the strain field as in the Eringen model and subsequent developments. At the limit the displacement field is found to be governed by an integro-differential equation, solved by a simple discretization procedure suggested by the underlying mechanical model itself…

Body forceNon-local elasticityDiscretizationField (physics)Mechanical EngineeringLinear elasticityConstitutive equationMathematical analysisCentral volume forceEquivalent mechanical modelThermodynamic consistencyContact forceLong-range interactionMechanics of MaterialsDisplacement fieldGeneral Materials ScienceBoundary value problemSettore ICAR/08 - Scienza Delle CostruzioniMathematicsJournal of Elasticity
researchProduct